Unlocking the Power of Adenosine

Adovate develops novel drugs that target adenosine receptors involved in major diseases. These drug candidates have been created using our next-generation adenosine drug development platform, which enable design of patented compounds with favorable physiochemical characteristics and distribution kinetics that historically limited drugs acting against the adenosine receptors.

Our adenosine platform is a cornerstone of our company and confers a competitive advantage that will allow us to broaden our future drug pipeline efficiently and economically

Adenosine and Adovate

Effective Delivery

Developing molecules with characteristics to enable high concentrations in target tissues (biodistribution).


Leadership with 125+ years of combined experience working with adenosine targets and drugs.

Robust Platform

Adenosine platform provides ability to develop drugs against numerous diseases and disorders.